CFDE Data Portal | Search AUP1

	Label	Description
	AUP1 Gene (Entity type)	ENSG00000115307 - AUP1 lipid droplet regulating VLDL assembly factor
	AUP1 associations Collection (Entity type)	Associations for AUP1_associations
	AUP1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	AUP1 HUMAN Protein (Entity type)	Lipid droplet-regulating VLDL assembly factor AUP1
	AUP1 MOUSE Protein (Entity type)	Lipid droplet-regulating VLDL assembly factor AUP1
	AUP1 RAT Protein (Entity type)	Lipid droplet-regulating VLDL assembly factor AUP1
	GSE207871 NPC knockdown S18 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE255432 7 V 3 IMEGLIMIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE145195 PPP2R3B overexpression 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE93156 idelalisib B cell 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

AUP1

ENSG00000115307 - AUP1 lipid droplet regulating VLDL assembly factor

AUP1 associations

Associations for AUP1_associations

AUP1 associations.tsv

A file from IDG as part of the Harmonizome project

AUP1 HUMAN

Lipid droplet-regulating VLDL assembly factor AUP1

AUP1 MOUSE

Lipid droplet-regulating VLDL assembly factor AUP1

AUP1 RAT

Lipid droplet-regulating VLDL assembly factor AUP1

GSE207871 NPC knockdown S18 1 v 0 human up

A Gene Set from LINCS

GSE255432 7 V 3 IMEGLIMIN MOUSE UP

A Gene Set from LINCS

GSE145195 PPP2R3B overexpression 0 v 1 human dn

A Gene Set from LINCS

GSE93156 idelalisib B cell 1 v 0 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.